37 results
PRE 14A
GLTO
Galecto Inc
16 Apr 24
Preliminary proxy
4:00pm
earlier death, resignation or removal;
2. To approve an amendment to the Company’s Amended and Restated Certificate of Incorporation to effect … as a Class I director of the Company until the Annual Meeting in 2027 and until her successor is duly elected and qualified, or until her earlier death
8-K
GLTO
Galecto Inc
15 Aug 23
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
8:00am
, were observed in 7.8% of patients in the GB0139 group and 1.4% of patients in the placebo group. Adverse events leading to death were similar in both
8-K
EX-99.1
wa8ps54datv
15 Aug 23
Galecto Announces Topline Results from Phase 2b GALACTIC-1 Trial of GB0139 for the Treatment of Idiopathic Pulmonary Fibrosis
8:00am
8-K
353jdtp
15 Jun 23
Submission of Matters to a Vote of Security Holders
4:00pm
8-K
EX-99.1
mua3d2z8
31 Oct 22
Galecto to Present Topline Data from GULLIVER-2 Clinical Trial Showing GB1211 Reduced Signs of Liver Impairment at AASLD’s The Liver Meeting® 2022
9:00am
8-K
68lm79oc n8
17 Jun 22
Submission of Matters to a Vote of Security Holders
7:00am
8-K
EX-99.1
es0qtz40
5 Jan 22
Regulation FD Disclosure
4:02pm
8-K
EX-10.1
hwydubx39vtbxd9uu8ih
6 Jul 21
Departure of Directors or Certain Officers
9:00am
8-K
msecyzrsko4 ydim6xu
28 May 21
Submission of Matters to a Vote of Security Holders
9:00am